Godsey & Gibb Associates Eli Lilly & CO Transaction History

Godsey & Gibb Associates

$1.04 Billion
Q3 2024

A detailed history of Godsey & Gibb Associates transactions in Eli Lilly & CO stock. As of the latest transaction made, Godsey & Gibb Associates holds 1,192 shares of LLY stock, worth $940,869. This represents 0.1% of its overall portfolio holdings.

Number of Shares

1,192

Previous 1,192 -0.0%

Holding current value

$940,869

Previous $1.08 Million 2.13%

% of portfolio

0.1%

Previous 0.11%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 23, 2024	SELL	$724.87 - $909.04 $10,873 - $13,635	-15 Reduced 1.24%	1,192 $1.08 Million
Q3 2023 Oct 25, 2023	SELL	$434.7 - $599.3 $6,520 - $8,989	-15 Reduced 1.23%	1,207 $648,000
Q2 2023 Jul 25, 2023	SELL	$350.74 - $468.98 $18,589 - $24,855	-53 Reduced 4.16%	1,222 $573,000
Q1 2023 Apr 18, 2023	SELL	$310.63 - $364.82 $31,063 - $36,482	-100 Reduced 7.27%	1,275 $437,000
Q4 2022 Jan 18, 2023	BUY	$321.55 - $374.67 $442,131 - $515,171	1,375 New	1,375 $0
Q1 2022 Apr 28, 2022	SELL	$234.69 - $291.66 $299,229 - $371,866	-1,275 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$221.6 - $272.71 $282,540 - $347,705	1,275 New	1,275 $295,000
Q2 2021 Aug 05, 2021	SELL	$180.55 - $233.54 $248,256 - $321,117	-1,375 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$164.32 - $212.72 $41,244 - $53,392	-251 Reduced 15.44%	1,375 $257,000
Q4 2020 Feb 12, 2021	SELL	$130.46 - $172.63 $38,485 - $50,925	-295 Reduced 15.36%	1,626 $275,000
Q3 2020 Nov 10, 2020	SELL	$146.22 - $169.13 $731 - $845	-5 Reduced 0.26%	1,921 $284,000
Q2 2020 Aug 12, 2020	BUY	$136.42 - $164.18 $682 - $820	5 Added 0.26%	1,926 $316,000
Q1 2020 May 11, 2020	SELL	$119.05 - $147.35 $2,976 - $3,683	-25 Reduced 1.28%	1,921 $266,000
Q3 2019 Nov 13, 2019	BUY	$106.79 - $116.16 $207,813 - $226,047	1,946 New	1,946 $218,000

Others Institutions Holding LLY

# of Institutions

4,007

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $750B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Godsey & Gibb Associates, based on Form 13F filings with the SEC.

News

Stay updated on Godsey & Gibb Associates with notifications on news.

Account

Godsey & Gibb Associates Eli Lilly & CO Transaction History